AMGN
Amgen Inc.
NASDAQ · USHealthcareDrug Manufacturers - General
$364.17-0.58%
Price as of Jul 20, 2026
AMGN valuation
Amgen Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 15.88x
- P/E 2026E
- 16.35x
- P/E 2027E
- 15.70x
- P/E 2028E
- 15.21x
- P/S forward
- 5.14x
Trailing multiples
- P/E TTM
- 25.15x
- PEG TTM
- 0.43x
- Price / book
- 21.39x
- Price / sales
- 5.28x
- Price / cash flow
- 18.27x
Enterprise value
- Enterprise value
- $241.8B
- EV / sales
- 6.49x
- EV / EBITDA
- 14.49x
- EV / EBIT
- 20.53x
- Market cap
- $196.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.